485 related articles for article (PubMed ID: 35477399)
1. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance.
Issa MS; Warsame M; Mahamat MHT; Saleh IDM; Boulotigam K; Djimrassengar H; Issa AH; Abdelkader O; Hassoumi M; Djimadoum M; Doderer-Lang C; Ndihiokubwayo JB; Rasmussen C; Menard D
Malar J; 2023 Aug; 22(1):240. PubMed ID: 37612601
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
Dorkenoo AM; Warsame M; Ataba E; Hemou M; Yakpa K; Sossou E; Mitigmsagou M; Teou CD; Caspar E; Ma L; Djadou KE; Atcha-Oubou T; Rasmussen C; Menard D
Malar J; 2024 Apr; 23(1):92. PubMed ID: 38570791
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.
Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM
Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039
[TBL] [Abstract][Full Text] [Related]
5. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
Wurtz N; Fall B; Pascual A; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Bercion R; Briolant S; Wade B; Pradines B
Malar J; 2012 Jun; 11():197. PubMed ID: 22694921
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.
Warsame M; Hassan AH; Hassan AM; Arale AM; Jibril AM; Mohamud SA; Barrette A; Muse AY; Yusuf FE; Nada RA; Amran JG
Trop Med Int Health; 2017 Apr; 22(4):415-422. PubMed ID: 28151566
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016.
Diarra Y; Koné O; Sangaré L; Doumbia L; Haidara DBB; Diallo M; Maiga A; Sango HA; Sidibé H; Mihigo J; Nace D; Ljolje D; Talundzic E; Udhayakumar V; Eckert E; Woodfill CJ; Moriarty LF; Lim P; Krogstad DJ; Halsey ES; Lucchi NW; Koita OA
Malar J; 2021 May; 20(1):235. PubMed ID: 34034754
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
[TBL] [Abstract][Full Text] [Related]
11. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group
Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375
[TBL] [Abstract][Full Text] [Related]
13. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
14. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
Berzosa P; Esteban-Cantos A; García L; González V; Navarro M; Fernández T; Romay-Barja M; Herrador Z; Rubio JM; Ncogo P; Santana-Morales M; Valladares B; Riloha M; Benito A
Malar J; 2017 Jan; 16(1):28. PubMed ID: 28086777
[TBL] [Abstract][Full Text] [Related]
15. Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar.
Rakotoarisoa MA; Fenomanana J; Dodoson BT; Andrianaranjaka VHI; Ratsimbasoa A
Malar J; 2022 Nov; 21(1):331. PubMed ID: 36376921
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone.
Smith SJ; Kamara ARY; Sahr F; Samai M; Swaray AS; Menard D; Warsame M
Acta Trop; 2018 Sep; 185():363-370. PubMed ID: 29932931
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.
Schramm B; Valeh P; Baudin E; Mazinda CS; Smith R; Pinoges L; Dhorda M; Boum Y; Sundaygar T; Zolia YM; Jones JJ; Comte E; Houzé P; Jullien V; Carn G; Kiechel JR; Ashley EA; Guérin PJ
Malar J; 2013 Jul; 12():251. PubMed ID: 23866774
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea.
Riloha Rivas M; Warsame M; Mbá Andeme R; Nsue Esidang S; Ncogo PR; Phiri WP; Oki Eburi C; Edú Maye CE; Menard D; Legrand E; Berzosa P; Garcia L; Lao Seoane AK; Ntabangana SC; Ringwald P
Malar J; 2021 Jun; 20(1):275. PubMed ID: 34158055
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
Marwa K; Kapesa A; Baraka V; Konje E; Kidenya B; Mukonzo J; Kamugisha E; Swedberg G
PLoS One; 2022; 17(3):e0264339. PubMed ID: 35271592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
